Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: Results of a dutch community setting trial for the clinical trial group of the comprehensive cancer centre

Marijke Bontenbal; GJ Creemers; HJ Braun; AC de Boer; JT Janssen; RB Leys; JB Ruit; SH (Swan Hoo) Goey; PC van der Velden; LG Kerkhofs; KL Schothorst; PI Schmitz; HJ Bokma; Jaap Verweij; Caroline Seynaeve

doi:10.1200/JCO.2005.06.236

Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: Results of a dutch community setting trial for the clinical trial group of the comprehensive cancer centre

Marijke Bontenbal, GJ Creemers, HJ Braun, AC de Boer, JT Janssen, RB Leys, JB Ruit, SH (Swan Hoo) Goey, PC van der Velden, LG Kerkhofs, KL Schothorst, PI Schmitz, HJ Bokma, Jaap Verweij, Caroline Seynaeve

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

90 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	7081-7088
Number of pages	8
Journal	Journal of Clinical Oncology
Volume	23
Issue number	28
DOIs	https://doi.org/10.1200/JCO.2005.06.236
Publication status	Published - 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2005.06.236

http://hdl.handle.net/1765/56673

Cite this

Bontenbal, M., Creemers, GJ., Braun, HJ., de Boer, AC., Janssen, JT., Leys, RB., Ruit, JB., Goey, SH., van der Velden, PC., Kerkhofs, LG., Schothorst, KL., Schmitz, PI., Bokma, HJ., Verweij, J., & Seynaeve, C. (2005). Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: Results of a dutch community setting trial for the clinical trial group of the comprehensive cancer centre. Journal of Clinical Oncology, 23(28), 7081-7088. https://doi.org/10.1200/JCO.2005.06.236

Bontenbal, Marijke ; Creemers, GJ ; Braun, HJ ; de Boer, AC ; Janssen, JT ; Leys, RB ; Ruit, JB ; Goey, SH (Swan Hoo) ; van der Velden, PC ; Kerkhofs, LG ; Schothorst, KL ; Schmitz, PI ; Bokma, HJ ; Verweij, Jaap ; Seynaeve, Caroline. / Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: Results of a dutch community setting trial for the clinical trial group of the comprehensive cancer centre. In: Journal of Clinical Oncology. 2005 ; Vol. 23, No. 28. pp. 7081-7088.

@article{186ff6faedc241f0b7fde3734469d083,

title = "Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: Results of a dutch community setting trial for the clinical trial group of the comprehensive cancer centre",

author = "Marijke Bontenbal and GJ Creemers and HJ Braun and {de Boer}, AC and JT Janssen and RB Leys and JB Ruit and Goey, {SH (Swan Hoo)} and {van der Velden}, PC and LG Kerkhofs and KL Schothorst and PI Schmitz and HJ Bokma and Jaap Verweij and Caroline Seynaeve",

year = "2005",

doi = "10.1200/JCO.2005.06.236",

language = "Undefined/Unknown",

volume = "23",

pages = "7081--7088",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "28",

}

Bontenbal, M, Creemers, GJ, Braun, HJ, de Boer, AC, Janssen, JT, Leys, RB, Ruit, JB, Goey, SH, van der Velden, PC, Kerkhofs, LG, Schothorst, KL, Schmitz, PI, Bokma, HJ, Verweij, J & Seynaeve, C 2005, 'Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: Results of a dutch community setting trial for the clinical trial group of the comprehensive cancer centre', Journal of Clinical Oncology, vol. 23, no. 28, pp. 7081-7088. https://doi.org/10.1200/JCO.2005.06.236

Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: Results of a dutch community setting trial for the clinical trial group of the comprehensive cancer centre. / Bontenbal, Marijke; Creemers, GJ; Braun, HJ; de Boer, AC; Janssen, JT; Leys, RB; Ruit, JB; Goey, SH (Swan Hoo); van der Velden, PC; Kerkhofs, LG; Schothorst, KL; Schmitz, PI; Bokma, HJ; Verweij, Jaap ; Seynaeve, Caroline.

In: Journal of Clinical Oncology, Vol. 23, No. 28, 2005, p. 7081-7088.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: Results of a dutch community setting trial for the clinical trial group of the comprehensive cancer centre

AU - Bontenbal, Marijke

AU - Creemers, GJ

AU - Braun, HJ

AU - de Boer, AC

AU - Janssen, JT

AU - Leys, RB

AU - Ruit, JB

AU - Goey, SH (Swan Hoo)

AU - van der Velden, PC

AU - Kerkhofs, LG

AU - Schothorst, KL

AU - Schmitz, PI

AU - Bokma, HJ

AU - Verweij, Jaap

AU - Seynaeve, Caroline

PY - 2005

Y1 - 2005

U2 - 10.1200/JCO.2005.06.236

DO - 10.1200/JCO.2005.06.236

M3 - Article

VL - 23

SP - 7081

EP - 7088

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 28

ER -

Bontenbal M, Creemers GJ, Braun HJ, de Boer AC, Janssen JT, Leys RB et al. Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: Results of a dutch community setting trial for the clinical trial group of the comprehensive cancer centre. Journal of Clinical Oncology. 2005;23(28):7081-7088. https://doi.org/10.1200/JCO.2005.06.236